Literature DB >> 121602

Prostaglandin synthetase and prostaglandin E2 levels in human breast carcinoma.

W E Kibbey, D G Bronn, J P Minton.   

Abstract

Prostaglandin synthetase activity and tissue prostaglandin E2 levels were measured in 53 human breast carcinoma specimens. Each set of data is log-normally distributed. There is a weak but statistically significant correlation between prostaglandin synthetase activity and tissue prostaglandin E2 levels of individual specimens. In addition, in a series of four rat mammary tumors, a rough correlation between prostaglandin synthetase activity and tissue prostaglandin E2 levels was observed. The data suggest a multifactorial explanation for abnormalities of prostaglandin metabolism in human breast cancer.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 121602     DOI： 10.1016/0161-4630(79)90048-x

Source DB:  PubMed          Journal:  Prostaglandins Med        ISSN： 0161-4630


  6 in total

1.  Role of natural prostaglandins in the control of murine mammary tumor virus expression.

Authors:  J Svec; P Svec; L Halcak; V Thurzo
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

2.  Prostaglandin E2 and cyclic AMP in tumor and plasma of breast cancer patients.

Authors:  T Malachi; C Chaimoff; N Feller; I Halbrecht
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

3.  Prostaglandin F2 alpha in benign and malignant breast tumours.

Authors:  I B Vergote; G M Laekeman; G H Keersmaekers; F L Uyttenbroeck; J S Vanderheyden; G P Albertyn; C F Haensch; G J De Roy; A G Herman
Journal:  Br J Cancer       Date:  1985-06       Impact factor: 7.640

4.  Prostaglandins in breast cancer: relationship to disease stage and hormone status.

Authors:  R A Karmali; S Welt; H T Thaler; F Lefevre
Journal:  Br J Cancer       Date:  1983-11       Impact factor: 7.640

5.  Prostacyclin and thromboxane in benign and malignant breast tumours.

Authors:  G M Laekeman; I B Vergote; G M Keersmaekers; J Heiremans; C F Haensch; G de Roy; F L Uyttenbroeck; A G Herman
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

6.  Breast cancer, prostaglandins and patient survival.

Authors:  A Bennett; I F Stamford; D A Berstock; F Dische; L Singh; R P A'Hern
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.